| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | $0 | $10.58 | 11 Jun 2024 | By Bristol Survivor's Trust |
| Eterna Therapeutics Inc. | Director | Stock Option (Right to buy) | 72,074 | 07 Feb 2025 | Direct | ||
| Erasca, Inc. | Director | Stock Option (right to buy) | 37,762 | 01 Jan 2026 | Direct |